Affiliation:
1. Assistant Professor, Nil Ratan Sircar Medical College and Hospital, Kolkata
2. Post Graduate Trainee, Nil Ratan Sircar Medical College and Hospital, Kolkata
Abstract
PURPOSE: The study aims to evaluate the safety of topical corticosteroids Loteprednol and
Flurometholone in treating VKC keeping in mind the efcacy of the drugs. METHOD: A prospective study
was done including 200 eyes of 107 patients with severe VKC (grade 3,4). 7 patients were lost during follow up. Patients were
selected randomly. 100 eyes of 50 patients were treated with Flurometholone 1% and another 100 eyes of 50 patients with
Loteprednol 0.5%. All patients were followed up over a period of 3 months. The study duration is 18 months. RESULT: The normal
IOP ranging between 10-21 mm Hg. Out of 100 eyes receiving urometholone in the study period of 18 months, 3 eyes (3%)
showed IOP ≥ 30mm Hg and 5 eyes (5%) showed IOP between 21-30mm Hg. Out of the rest 100 eyes receiving Loteprednol, 3
eyes (3%) showed IOP between 21-30 mm Hg while none (0%) reached an IOP over 30 mm Hg. CONCLUSION: Loteprednol is
more effective than Flurometholone and it consistently demonstrated a low propensity to elevate IOP, regardless of formulation,
dosage regimen both during short term as well as long term treatment of VKC patient.
Reference14 articles.
1. Beigelman MN. Vernal Conjunctivitis. University of Southern California Press: Los Angeles, 1950.
2. Donshik PC, Ehlers WH. Clinical immunologic diseases. In: Srolin G, Thoft RA (eds). The Cornea, 3rd ed, chap. 12. Little, Brown & Company: Boston, 1994.
3. Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 2000; 107: 1157–1163.
4. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson Jr NF, Kagey-Sobotka A et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985; 76: 1375–1381.
5. Trocme SD, Aldave AJ. The eye and the eosinophil. Surv Ophthalmol 1994; 39: 241–252.